Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yijia Hua

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Medcomm|June 21, 2024
Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world studyChunxiao Sun, Yijia Hua, Nan Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2021
Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysisXueqi Yan, Yinghong Xie, Fan Yang, et al.
International Journal of Cancer|May 20, 2020
Relationship between tRNA-derived fragments and human cancersTianyu Zeng, Yijia Hua, Chunxiao Sun, et al.
Cancers|February 11, 2023
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast CancerChunxiao Sun, Xiang Huang, Jun Li, et al.
Cell Death Discovery|April 13, 2022
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progressionXueqi Yan, Yaozhou He, Shikun Yang, et al.
Frontiers in Oncology|August 16, 2021
Risk Signature of Cancer-Associated Fibroblast-Secreted Cytokines Associates With Clinical Outcomes of Breast CancerChunxiao Sun, Siwei Wang, Yuchen Zhang, et al.
International Journal of Biological Sciences|August 8, 2024
<i>tRF-27</i> competitively Binds to G3BPs and Activates MTORC1 to Enhance HER2 Positive Breast Cancer Trastuzumab ToleranceYaozhou He, Yincheng Liu, Jue Gong, et al.
Annals of Translational Medicine|September 17, 2021
Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trialsShengnan Bao, Yuanping Yue, Yijia Hua, et al.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Medcomm|June 21, 2024
Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world studyChunxiao Sun, Yijia Hua, Nan Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 28, 2021
Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysisXueqi Yan, Yinghong Xie, Fan Yang, et al.
International Journal of Cancer|May 20, 2020
Relationship between tRNA-derived fragments and human cancersTianyu Zeng, Yijia Hua, Chunxiao Sun, et al.
Cancers|February 11, 2023
Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast CancerChunxiao Sun, Xiang Huang, Jun Li, et al.
Cell Death Discovery|April 13, 2022
A positive feedback loop: RAD18-YAP-TGF-β between triple-negative breast cancer and macrophages regulates cancer stemness and progressionXueqi Yan, Yaozhou He, Shikun Yang, et al.
Frontiers in Oncology|August 16, 2021
Risk Signature of Cancer-Associated Fibroblast-Secreted Cytokines Associates With Clinical Outcomes of Breast CancerChunxiao Sun, Siwei Wang, Yuchen Zhang, et al.
International Journal of Biological Sciences|August 8, 2024
<i>tRF-27</i> competitively Binds to G3BPs and Activates MTORC1 to Enhance HER2 Positive Breast Cancer Trastuzumab ToleranceYaozhou He, Yincheng Liu, Jue Gong, et al.
Annals of Translational Medicine|September 17, 2021
Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trialsShengnan Bao, Yuanping Yue, Yijia Hua, et al.
Cancer Medicine|October 13, 2021
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population-based studyShengnan Bao, Mengping Jiang, Xi Wang, et al.
Pageof 2